Malmström and colleagues 7 collected individual patient data from previous trials of BCG versus mitomycin C and performed a meta-analysis on 2,820 such data sets. After a median follow-up of 4.4 ...
Adjuvant, intravesical bacillus Calmette–Guérin (BCG) therapy reduces the risk of recurrence and progression of superficial bladder cancer, but confers a considerable risk of local and systemic ...
We conducted a meta-analysis of published data including recently published studies (up to June 2009) to determine the efficacy of BCG protection on leprosy and to investigate whether age at ...
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Abstract/Posters Session. Dr Madison Wahlen discussed ...
Bladder cancer ranks as the 10th most commonly diagnosed cancer globally, affecting both men and women. Approximately 75% of patients are initially diagnosed with non-muscle invasive bladder cancer ...
(B) The report delivers a comprehensive analysis of global, regional, and country-level AI in fintech market revenues, extending projections until 2030. This dataset empowers companies to gauge their ...
BCG, in their 2024 annual asset management report ... and enhances private market information/risk analysis. Boosting Productivity: The report details several examples of how use of AI can ...
The symbol of Brightcom Group Ltd is BCG. What is the PE ratio of Brightcom ... reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.